This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

    More

    Page   1/5   
  • Measuring the return from pharmaceutical innovation 2012
    For the last three years, Deloitte LLP and Thomson Reuters have analysed the performance of the top 12 life sciences companies by estimating the projected financial returns from the investment in their late stage pipelines.
  • State of the Swiss Medical Technology Industry 2011
    Today’s economy exposes any marginal innovation, compliance and quality gaps faster globally, thus influencing performance of companies.
  • 2011 Survey of Health Care Consumers in Switzerland
    This 2011 Survey of Health Care offers industry leaders and policy makers a look at the changing behaviors, attitudes, and unmet needs of health care consumers in Switzerland and provides an opportunity to compare and contrast this country's system with others.
    • Page   1/5   
Stay connected

© 2013 Deloitte AG. All rights reserved. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity.

Please see About Deloitte for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its Member Firms.

Get connected
Share your comments
More on Deloitte